Colorectal cancer is
the third most common cancer among men and the second among women.
Most of these cancers develop from adenomatous polyps in a period
that can be ten years or more. This long progression offers enough
time to adopt preventive strategies with reasonable levels of
effectiveness in a context of a mucosa where the presence of polyps
is fairly common, despite only some of them evolving toward
malignancy.
Colonoscopy is a
technique that has been proven effective in reducing mortality from
colorectal cancer, but no one can ignore the difficulties of applying
this technique extensively, given the low adherence to the calls and
the high costs of the program, without forgetting the side effects
inherent to the practice of colonoscopy. For this reason I thought it
opportune the study lead by Dr. Enrique Quintero (Hospital
Universitario de Canarias) and Dr. Antoni Castells (Hospital Clínic Barcelona)
which compares, in a prospective clinical trial involving more than
50,000 calls, the practice of a one time colonoscopy with the
analysis of a stool sample (with immunochemical test) every two
years. The work has an expected 10-year follow-up, and aims to
measure the impact in terms of deaths avoided, and although it is
still evolving, New England has published a progress report.
